| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2021cafa8df7b0dec20ae2c7682f639 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605 |
| filingDate |
2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f76434691e89a4233c47d072ab89ad53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d85862e4c79fda5b5b6676063df189d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a52f09429b2d70044b0ecbe015856f9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cf67ed3a7efde91dce2f398ab365d1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_444f6f5a4156b462570df853bd9e9e8b |
| publicationDate |
2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112019025195-A2 |
| titleOfInvention |
PROLONGED ACTION PEPTIDE ANALOGS |
| abstract |
the present invention relates to peptide analogs derived from the glucose-dependent insulinotropic peptide (gip) gip5-30 and gip3-30 which are antagonists of the gip receptor, and comprises at least one fatty acid molecule to increase the half-life, maintaining at the same time the antagonistic properties. |
| priorityDate |
2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |